Ciclosporin Inhibits the Effector Function of the T Effector Cell of Delayed Type Hypersensitivity

  • M. Braida
  • J. Knop
Conference paper

Abstract

A substantial body of data demonstrates the immunosuppressive properties of the fungal metabolite cyclosporin A (CyA). Several T cell responses such as a mixed leukocyte reaction and lectin mitogenesis are blocked by this drug. It has been suggested that CyA inhibits the first stages of the T cell responses by suppressing the T cell stimulatory signals leading to activation and proliferation. It has been shown that CyA prevents the expression of receptors for T cell growth factor interleukin 2 [5] and in addition depresses the production of IL2 via a pathway involving inhibition of IL 1. The delayed type hypersensitivity reaction to various antigens is usually depressed by CyA, particularly if it is administered during the induction phase [2]. However, recent investigations have shown that in various in vivo delayed type hypersensitivity models cyclosporin A may even enhance the immune response, depending on the time of administration [6]. We have used contact sensitivity to 2,4dinitrofluorobenzene (DNFB) in mice as a model of delayed type hypersensitivity to study the effects of CyA on this reaction. By transferring T effector cells of delayed type hypersensitivity (TDH cells) to naive recipients we were able to show that CyA does not inhibit the induction of this T subpopulation but very efficently blocks its functional expression in the recipient animal. CyA may even enhance the immune response if a suppressive dose (antigen overload) of the contact sensitizer is applied to the skin.

Keywords

Interferon Cyclosporin Dermatitis Sarcoidosis Dermatol 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Altmann DM, Blyth WA (1985) The effects of cyclosporin A on the induction, expression and regulation of the immune response to Herpes simplex virus. Clin Exp Immunol 15:17Google Scholar
  2. 2.
    Borel JF, Lafferty KJ (1983) Cyclosporin A: speculation about its mechanism of action. Transplant Proc XV:1881Google Scholar
  3. 3.
    Knop J, Riechmann R, Macher E (1981) Modulation of suppressor mechanisms in allergic contact dermatitis: 1. Effect of C. parvum on the induction phase of contact allergy. J Invest Dermatol 76:193PubMedCrossRefGoogle Scholar
  4. 4.
    Knop J, Stremmer R, Taborski U, Freitag W, De Maeyer-Guignard J, Macher E (1984) Inhibition of the T-suppressor circuit of delayed-type hypersensitivity by interferon. J Immunol 133:2412PubMedGoogle Scholar
  5. 5.
    Larsson EL (1980) Cyclosporin A and dexamethasone suppress T-cell responses by selectivity acting at distinct sites of the triggering process. J Immunol 124:2828PubMedGoogle Scholar
  6. 6.
    Thomson AW, Moon DK, Inoue Y, Geczy CL, Nelson DS (1983) Modification of delayed-type hypersensitivity reactions to ovalbumin in cyclosporin A-treated guinea-pigs. Immunology 48:301PubMedGoogle Scholar

Copyright information

© Sandoz Ltd, Basle 1985

Authors and Affiliations

  • M. Braida
  • J. Knop
    • 1
  1. 1.Universitäts-Hautklinik MünsterGermany

Personalised recommendations